382 related articles for article (PubMed ID: 16076687)
1. Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test.
Mendelsohn EE; Solum NO; Brosstad F
Scand J Clin Lab Invest; 2005; 65(4):321-32. PubMed ID: 16076687
[TBL] [Abstract][Full Text] [Related]
2. Method for in vitro analysis of nanoparticle thrombogenic properties.
Neun BW; Dobrovolskaia MA
Methods Mol Biol; 2011; 697():225-35. PubMed ID: 21116972
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
[TBL] [Abstract][Full Text] [Related]
4. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
5. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
[TBL] [Abstract][Full Text] [Related]
6. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
7. The role of whole blood in thrombin generation in contact with various titanium surfaces.
Thor A; Rasmusson L; Wennerberg A; Thomsen P; Hirsch JM; Nilsson B; Hong J
Biomaterials; 2007 Feb; 28(6):966-74. PubMed ID: 17095084
[TBL] [Abstract][Full Text] [Related]
8. The procoagulant effect of platelets on conversion of prothrombin to thrombin in nonanticoagulated plasma.
White BN; Cox AC; Taylor FB
J Lab Clin Med; 1980 Jun; 95(6):827-41. PubMed ID: 7381294
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of factors that can modify platelet-rich plasma properties.
Andrade MG; de Freitas Brandão CJ; Sá CN; de Bittencourt TC; Sadigursky M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e5-e12. PubMed ID: 18155603
[TBL] [Abstract][Full Text] [Related]
10. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets.
Chen YW; Chen JK; Wang JS
Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321
[TBL] [Abstract][Full Text] [Related]
11. Activation of platelet-rich plasma using thrombin receptor agonist peptide.
Landesberg R; Burke A; Pinsky D; Katz R; Vo J; Eisig SB; Lu HH
J Oral Maxillofac Surg; 2005 Apr; 63(4):529-35. PubMed ID: 15789326
[TBL] [Abstract][Full Text] [Related]
12. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
[TBL] [Abstract][Full Text] [Related]
13. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-tocopherol on platelets and the coagulation system.
Bakaltcheva I; Gyimah D; Reid T
Platelets; 2001 Nov; 12(7):389-94. PubMed ID: 11674855
[TBL] [Abstract][Full Text] [Related]
15. The contribution of platelets in the production of cryoprecipitates for use in a fibrin glue.
Rock G; Neurath D; Lu M; Alharbi A; Freedman M
Vox Sang; 2006 Oct; 91(3):252-5. PubMed ID: 16958838
[TBL] [Abstract][Full Text] [Related]
16. A lupus anticoagulant neutralization procedure using the patient's own platelets.
Carroll P; Ray M; Just S; Hawson G
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308
[TBL] [Abstract][Full Text] [Related]
17. No differences in support of thrombin generation by neonatal or adult platelets.
Bernhard H; Rosenkranz A; Novak M; Leschnik B; Petritsch M; Rehak T; Köfeler H; Ulrich D; Muntean W
Hamostaseologie; 2009 Oct; 29 Suppl 1():S94-7. PubMed ID: 19763359
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference.
Okuda M; Yamamoto Y
Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321
[TBL] [Abstract][Full Text] [Related]
19. Standardization and clinical utility of thrombin-generation assays.
Berntorp E; Salvagno GL
Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
[TBL] [Abstract][Full Text] [Related]
20. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
Kumar R; Béguin S; Hemker HC
Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
